Hemodynamic instability and right ventricular (RV) dysfunction are the key determinants of
short-term prognosis in patients with acute pulmonary embolism (PE). High-risk PE …

Pulmonary embolism (PE) is a common disease with an annual incidence rate ranging from
39–115 per 100,000 inhabitants. It is one of the leading causes of cardiovascular mortality in …

According to the European guidelines, high-risk pulmonary embolism (PE) is defined as PE
associated with hemodynamic instability, including sustained hypotension, cardiogenic …

Pulmonary embolism (PE) is a common and important medical emergency, encountered by
clinicians across all acute care specialties. PE is a relatively uncommon cause of direct …

Pulmonary embolism (PE) continues to represent a significant health care burden and its
incidence is steadily increasing worldwide. Constantly evolving therapeutic options and the …

Introduction This study aimed to evaluate the effect of different reperfusion strategies on
neurological outcomes in patients with pulmonary embolism who received venoarterial …

In this review, the current status of the worldwide experience on different catheter-directed
treatment systems utilized as alternative reperfusion methods in acute pulmonary embolism …

High-risk/massive pulmonary embolism (PE) has a high mortality rate, especially when
cardiac arrest occurs. Venoarterial (VA) extracorporeal membrane oxygenation (ECMO) can …

Background The impact of major changes in the treatment practice of pulmonary embolism
(PE), such as limited indications for systemic thrombolysis and the introduction of direct oral …

Pulmonary embolism (PE) is a common disease associated with high morbidity and
mortality. Currently, guidelines recommend systemic thrombolysis in patients with …